Advertisement
Mindray Medical International Limited introduces its A5 Anesthesia System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The A5 anesthesia device, part of the all new A Series portfolio, is an anesthesia delivery platform that will complement Mindray's broad range of existing ultrasound and patient monitoring systems.

Mindray Medical International Limited introduces its A5 Anesthesia System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The A5 anesthesia device, part of the all new A Series portfolio, is an anesthesia delivery platform that will complement Mindray's broad range of existing ultrasound and patient monitoring systems.

The A5's intuitive user interface and ergonomic design simplify workflows. Meanwhile, its 15" touch screen enables clinicians to quickly and easily select ventilation settings, so less time is spent maneuvering and more time is devoted to patient care. The ample work surface, central brake and integrated cable sweeps enhance effectiveness and device mobility.

A5 is the first and only anesthesia machine that conforms to the IHE (Integrating the Healthcare Enterprise) Patient Care Domain (PCD) profile. At no additional charge, every A5 provides data output in the industry standard HL7 protocol. HL7, with the IHE PCD profile, is recognized among anesthesia information management systems (AIMS) and electronic medical records (EMR) systems as the demonstrated industry standard for unambiguous interoperability.

The A5 provides a range of advanced ventilation modes enabling effective care across different patient acuity types. Integrated spirometry offers additional information which enhances careful decision making.

The unique, auxiliary O2/Air Blender reduces the risk of surgical fires by controlling the oxygen concentration under the drape, near the patient's head and chest.

For more information, visit http://www.mindray.com

Advertisement
Advertisement